NXTC

NASDAQ · Biotechnology

Nextcure Inc

Biotech Stocks Healthcare Stocks

$11.10

+0.01 (+0.09%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +217.6% upside

Low Target $27.20

Average Target $35.25

High Target $53.45

Current Price $11.10

Current
$11.10

Target
$35.25

$27.20 $35.25 avg $53.45

Scenario Analysis

Bear Case

$27.20

145.0%

Low target

Base Case

$35.25

+217.6%

Avg target

Bull Case

$53.45

+381.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$38.76

-71.4% from high

52-Week Low

$22.58

+-50.8% from low

Target vs 52W High

$35.25

-9.1% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-2.47

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%